Asterand Lands $5.4M NCI Contract | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asterand said today that it has won a contract from the National Institutes of Health valued at up to $24.3 million to support The Cancer Genome Atlas program.

Under the National Cancer Institute contract, which gives Asterand $5.4 million over a 17-month period and includes an option for renewal, the firm will supply clinically annotated human biospecimens to NCI for use in TCGA projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.